Treatment of the cancer cells (PC-3 and DU-145) with IL-6 led to significant IGF-1Ec isoform upregulation in both prostate cancer cell lines (p = 0.0096 and p = 0,001 respectively, students t test, n = 5). Here, IL6 is linked to prostate cancer.